Casdin Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.9M | Buy |
990,097
+89,314
| +10% | +$1.53M | 1.54% | 14 |
|
2025
Q1 | $57.5M | Sell |
900,783
-172,717
| -16% | -$11M | 4.7% | 6 |
|
2024
Q4 | $131M | Hold |
1,073,500
| – | – | 8.69% | 4 |
|
2024
Q3 | $134M | Hold |
1,073,500
| – | – | 8.94% | 5 |
|
2024
Q2 | $170M | Buy |
1,073,500
+4,500
| +0.4% | +$711K | 12.95% | 3 |
|
2024
Q1 | $138M | Buy |
1,069,000
+62,500
| +6% | +$8.09M | 10.29% | 4 |
|
2023
Q4 | $97.1M | Sell |
1,006,500
-3,830
| -0.4% | -$369K | 9.53% | 3 |
|
2023
Q3 | $122M | Sell |
1,010,330
-4,670
| -0.5% | -$566K | 13.55% | 1 |
|
2023
Q2 | $116M | Sell |
1,015,000
-145,000
| -13% | -$16.6M | 10.16% | 2 |
|
2023
Q1 | $160M | Sell |
1,160,000
-155,000
| -12% | -$21.4M | 13.17% | 2 |
|
2022
Q4 | $170M | Buy |
1,315,000
+90,000
| +7% | +$11.7M | 13.2% | 1 |
|
2022
Q3 | $135M | Buy |
1,225,000
+575,000
| +88% | +$63.6M | 8.9% | 3 |
|
2022
Q2 | $48.7M | Sell |
650,000
-150,000
| -19% | -$11.2M | 4.12% | 9 |
|
2022
Q1 | $62.5M | Sell |
800,000
-550,000
| -41% | -$43M | 2.8% | 14 |
|
2021
Q4 | $122M | Buy |
1,350,000
+250,000
| +23% | +$22.5M | 3.43% | 12 |
|
2021
Q3 | $102M | Buy |
1,100,000
+215,000
| +24% | +$19.9M | 2.53% | 13 |
|
2021
Q2 | $68.8M | Buy |
885,000
+335,000
| +61% | +$26M | 1.75% | 20 |
|
2021
Q1 | $41M | Buy |
550,000
+20,000
| +4% | +$1.49M | 1.22% | 23 |
|
2020
Q4 | $90.4M | Hold |
530,000
| – | – | 2.68% | 13 |
|
2020
Q3 | $74.4M | Hold |
530,000
| – | – | 3.33% | 9 |
|
2020
Q2 | $85M | Sell |
530,000
-140,000
| -21% | -$22.4M | 5.03% | 4 |
|
2020
Q1 | $65.5M | Hold |
670,000
| – | – | 6.96% | 2 |
|
2019
Q4 | $86.5M | Sell |
670,000
-210,000
| -24% | -$27.1M | 7.95% | 1 |
|
2019
Q3 | $66.3M | Buy |
880,000
+545,000
| +163% | +$41M | 6.86% | 5 |
|
2019
Q2 | $50.9M | Buy |
335,000
+30,000
| +10% | +$4.56M | 4.76% | 8 |
|
2019
Q1 | $36.4M | Buy |
305,000
+155,000
| +103% | +$18.5M | 3.99% | 13 |
|
2018
Q4 | $16.4M | Buy |
150,000
+110,000
| +275% | +$12M | 2.8% | 16 |
|
2018
Q3 | $6.46M | Buy |
+40,000
| New | +$6.46M | 0.79% | 29 |
|